Filing Details

Accession Number:
0001062993-25-002706
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-18 16:49:57
Reporting Period:
2025-02-14
Filing Date:
2025-02-18
Accepted Time:
2025-02-18 16:49:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
842023 Bio-Techne Corp TECH Biological Products, (No Disgnostic Substances) (2836) 411427402
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2055523 E. Amy Herr 614 Mckinley Place Ne
Minneapolis MN 55413
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-02-14 1,976 $44.33 3,836 No 4 M Indirect By significant other
Common Stock Disposition 2025-02-14 1,860 $65.96 1,976 No 4 S Indirect By significant other
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect By significant other
No 4 S Indirect By significant other
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2025-02-14 1,976 $0.00 3,256 $44.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,280 2025-08-08 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,040 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $72.05 2035-02-03 2,415 2,415 Direct
Common Stock Stock Option (Right to Buy) $47.60 2026-08-07 6,636 6,636 Indirect
Common Stock Stock Option (Right to Buy) $66.97 2027-08-05 4,472 4,472 Indirect
Common Stock Stock Option (Right to Buy) $120.46 2028-08-06 2,076 2,076 Indirect
Common Stock Stock Option (Right to Buy) $94.52 2029-08-15 2,104 2,104 Indirect
Common Stock Stock Option (Right to Buy) $84.61 2030-08-15 1,084 1,084 Indirect
Common Stock Stock Option (Right to Buy) $74.91 2034-08-15 1,468 1,468 Indirect
Common Stock Stock Option (Right to Buy) $72.05 2025-02-03 344 344 Indirect
Common Stock Restricted Stock Units $0.00 237 237 Indirect
Common Stock Restricted Stock Units $0.00 480 480 Indirect
Common Stock Restricted Stock Units $0.00 115 115 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2035-02-03 2,415 2,415 Direct
2026-08-07 6,636 6,636 Indirect
2027-08-05 4,472 4,472 Indirect
2028-08-06 2,076 2,076 Indirect
2029-08-15 2,104 2,104 Indirect
2030-08-15 1,084 1,084 Indirect
2034-08-15 1,468 1,468 Indirect
2025-02-03 344 344 Indirect
237 237 Indirect
480 480 Indirect
115 115 Indirect
Footnotes
  1. The option vests on the earlier of the one-year anniversary of the grant date or the date of Bio-Techne's annual meeting of shareholders.
  2. Fully vested.
  3. 520 shares vest on each of 8/6/2022, 8/6/2023 and 8/6/2025; and 516 shares vest on 8/6/2024.
  4. 528 shares vest on 8/15/2023 and 8/15/2025; 524 shares vest on 8/15/2024 and 8/15/2026.
  5. 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
  6. 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
  7. 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
  8. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  9. 119 restricted stock units vest on 8/15/2025 and 118 restricted stock units vest on 8/15/2026.
  10. 160 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
  11. 38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.